111 related articles for article (PubMed ID: 36857949)
1. The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line.
Ozisik H; Ozdil B; Suner A; Sipahi M; Erdogan M; Cetinkalp S; Ozgen G; Saygili F; Oktay G; Aktug H
Pathol Res Pract; 2023 Mar; 243():154385. PubMed ID: 36857949
[TBL] [Abstract][Full Text] [Related]
2. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
3. BRAFV600E and RET/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-κB.
Zhou D; Li Z; Bai X
Med Sci Monit; 2017 Nov; 23():5321-5329. PubMed ID: 29117154
[TBL] [Abstract][Full Text] [Related]
4. Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a.
Long M; Zhu Y; Chen Z; Lin S; Peng X; Luo D; Li H; Tan L
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303750
[TBL] [Abstract][Full Text] [Related]
5. High iodine effects on the proliferation, apoptosis, and migration of papillary thyroid carcinoma cells as a result of autophagy induced by BRAF kinase.
Zhang D; Xu X; Li J; Yang X; Sun J; Wu Y; Qiao H
Biomed Pharmacother; 2019 Dec; 120():109476. PubMed ID: 31563816
[TBL] [Abstract][Full Text] [Related]
6. [Effects of UHRF1 on Estrogen Receptor and Proliferation, Invasion and Migration of BCPAP Cells in Thyroid Papillary Carcinoma].
Xu LW; Zhang LY; Gou X; Qiu YB; Liu ZM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):325-330. PubMed ID: 32543137
[TBL] [Abstract][Full Text] [Related]
7. AXL, along with PROS1, is overexpressed in papillary thyroid carcinoma and regulates its biological behaviour.
Wei M; Wang Y; Liu Y; Li D; He X
World J Surg Oncol; 2022 Oct; 20(1):334. PubMed ID: 36203174
[TBL] [Abstract][Full Text] [Related]
8. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
9. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
Sun Y; Zhang L; Zhang S
Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
[TBL] [Abstract][Full Text] [Related]
10.
Wang R; He Y; Wang Y; Xie S
Front Biosci (Landmark Ed); 2023 Jan; 28(1):17. PubMed ID: 36722273
[TBL] [Abstract][Full Text] [Related]
11. ret/PTC-1 expression alters the immunoprofile of thyroid follicular cells.
Denning K; Smyth P; Cahill S; Li J; Flavin R; Aherne S; O' Leary JJ; Sheils O
Mol Cancer; 2008 May; 7():44. PubMed ID: 18505566
[TBL] [Abstract][Full Text] [Related]
12. Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222.
Lee JC; Zhao JT; Gundara J; Serpell J; Bach LA; Sidhu S
J Surg Res; 2015 Jun; 196(1):39-48. PubMed ID: 25819770
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.
Wang Y; Lin X; Fu X; Yan W; Lin F; Kuang P; Luo Y; Lin E; Hong X; Wu G
Oncol Rep; 2018 Aug; 40(2):859-866. PubMed ID: 29917164
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
15. LARP7 in papillary thyroid carcinoma induces NIS expression through suppression of the SHH signaling pathway.
Sui X; Sui Y; Wang Y
Mol Med Rep; 2018 Jun; 17(6):7521-7528. PubMed ID: 29620212
[TBL] [Abstract][Full Text] [Related]
16. Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo.
Shen CT; Wei WJ; Qiu ZL; Song HJ; Zhang XY; Sun ZK; Luo QY
J Mol Endocrinol; 2017 Jan; 58(1):15-23. PubMed ID: 27920093
[TBL] [Abstract][Full Text] [Related]
17. JAZF1 Suppresses Papillary Thyroid Carcinoma Cell Proliferation and Facilitates Apoptosis via Regulating TAK1/NF-κB Pathways.
Huang L; Cai Y; Luo Y; Xiong D; Hou Z; Lv J; Zeng F; Yang Y; Cheng X
Onco Targets Ther; 2019; 12():10501-10514. PubMed ID: 31819531
[TBL] [Abstract][Full Text] [Related]
18. Differential glycolytic profile and Warburg effect in papillary thyroid carcinoma cell lines.
Coelho RG; Cazarin JM; Cavalcanti de Albuquerque JP; de Andrade BM; Carvalho DP
Oncol Rep; 2016 Dec; 36(6):3673-3681. PubMed ID: 27748844
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway.
Wei T; Zhu X
J Bioenerg Biomembr; 2021 Aug; 53(4):429-440. PubMed ID: 34032966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]